India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode, host Vikas Dandekar is joined by Namita Thapar, Executive Director, Emcure Pharmaceuticals, Aman Mehta, Managing Director, Torrent Pharma, and Sharvil Patel, Managing Director, Zydus Lifesciences to explore what it takes to climb the innovation ladder. From regulatory roadblocks and pricing pressures to building a robust R&D ecosystem, the panel lays it all out. Patel reflects on Zydus’ early bet on research, Thapar shares Emcure’s commitment to women’s health and inclusive leadership, while Mehta highlights the shift toward patient-first thinking. Blending sharp insights, real-world data, and candid personal stories, this conversation asks the big question: Can India go from being the “pharmacy of the world” to becoming its “laboratory”?

You can follow Vikas Dandekar on his social media: Twitter and Linkedin and read her Newspaper Articles.

Listen to the first installment of Corner Office Conversation called Corner Office Conversation with Pawan Goenka, Chairman, IN-SPACe

Catch the latest episode of the new show “Corner Office Conversation” on: Spotify, Amazon Music, Apple Podcasts,and wherever you get your podcasts from.

See omnystudio.com/listener for privacy information.

Pensioni, come cambiano dal 2023 e quanto costa il riscatto della laurea